Mehra, Ranee
Seiwert, Tanguy Y.
Gupta, Shilpa
Weiss, Jared
Gluck, Iris
Eder, Joseph P.
Burtness, Barbara
Tahara, Makoto
Keam, Bhumsuk
Kang, Hyunseok
Muro, Kei
Geva, Ravit
Chung, Hyun Cheol
Lin, Chia-Chi
Aurora-Garg, Deepti
Ray, Archana
Pathiraja, Kumudu
Cheng, Jonathan
Chow, Laura Q. M.
Haddad, Robert
Article History
Received: 30 November 2017
Revised: 26 April 2018
Accepted: 10 May 2018
First Online: 29 June 2018
Consent for publication
: All authors had full access to all the data in the study, contributed to reviewing and revising the manuscript, and had final responsibility for the decision to submit for publication.
: T.Y.S., J.W., B.B., and H.K. have received research funding from Merck & Co., Inc. M.T. has received personal fees from Merck Sharp & Dohme. D.A.-G., A.R., K.P., and J.C. are employees Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. L.Q.C. has served as an advisor for and has received research from Merck & Co., Inc. R.H. has received research funding from Merck & Co., Inc., Bristol-Myers Squibb, Pfizer, and Astra Zeneca, and has served as a consultant for Merck & Co., Inc., Bristol-Myers Squibb, Pfizer, Celgene, Astra Zeneca, and Eisai. The remaining authors declare no competing interests.
: The original studies were conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki, and the study protocol was approved by institutional review boards or ethics committees of all participating sites.
: Merck & Co., Inc.’s data sharing policy including restrictions is available at ExternalRef removed. Requests for access to the clinical study data can be submitted through the EngageZone site or via email to dataaccess@merck.com.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International licence (CC BY 4.0).